OWA
GSK icon

Opal Wealth Advisors’s GSK GSK Stock Holding History

Opal Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-899
Closed -$49.6K – 376
2026
Q1 		$49.6K Buy
+899
New +$48.7K 0.01% 404
2025
Q3 		– Sell
-1,474
Closed -$56.6K – 335
2025
Q2 		$56.6K Buy
+1,474
New +$56.3K 0.02% 358
2024
Q3 		– Sell
-451
Closed -$17.4K – 598
2024
Q2 		$17.4K Buy
+451
New +$19K 0.01% 544

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Opal Wealth Advisors's GSK Position: Q2 2026 in Review

Opal Wealth Advisors sold out of GSK (GSK) in Q2 2026, closing a stake of 899 shares — an estimated $49.6K sold.

Opal Wealth Advisors first reported a position in GSK in Q2 2024 and held it in 3 quarters. The position peaked at $56.6K in Q2 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Opal Wealth Advisors reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 899 GSK shares in Q2 2026, an estimated $49.6K.
  • Opal Wealth Advisors first reported a position in GSK in Q2 2024 and held it in 3 quarters.
  • Opal Wealth Advisors's GSK position peaked at $56.6K in Q2 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.